nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—Olopatadine—S100A1—ocular cancer	0.684	1	CrCbGaD
Nortriptyline—HTR2C—Signaling Pathways—CDKN2B—ocular cancer	0.000146	0.000461	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GNA11—ocular cancer	0.000145	0.000457	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HDAC1—ocular cancer	0.000143	0.000454	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HDAC1—ocular cancer	0.000141	0.000446	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HDAC1—ocular cancer	0.000141	0.000445	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HDAC1—ocular cancer	0.00014	0.000444	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HDAC1—ocular cancer	0.00014	0.000443	CbGpPWpGaD
Nortriptyline—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00014	0.000442	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CDKN2B—ocular cancer	0.000139	0.000441	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HDAC1—ocular cancer	0.000138	0.000438	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HDAC1—ocular cancer	0.000138	0.000437	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GNAQ—ocular cancer	0.000134	0.000425	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—E2F1—ocular cancer	0.000134	0.000425	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—E2F1—ocular cancer	0.000134	0.000423	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GNA11—ocular cancer	0.00013	0.000411	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000129	0.000407	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000128	0.000405	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	0.000126	0.0004	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN2B—ocular cancer	0.000126	0.000399	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN2B—ocular cancer	0.000126	0.000398	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN2B—ocular cancer	0.000125	0.000397	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	0.000124	0.000393	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000124	0.000392	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000121	0.000382	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GNA11—ocular cancer	0.000119	0.000378	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—EP300—ocular cancer	0.000119	0.000377	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GNA11—ocular cancer	0.000118	0.000374	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000118	0.000373	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—E2F1—ocular cancer	0.000116	0.000367	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—E2F1—ocular cancer	0.000116	0.000366	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—E2F1—ocular cancer	0.000115	0.000365	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—E2F1—ocular cancer	0.000115	0.000364	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—E2F1—ocular cancer	0.000114	0.000361	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000114	0.00036	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000111	0.000351	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GNAQ—ocular cancer	0.00011	0.000348	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MDM2—ocular cancer	0.00011	0.000347	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000108	0.000343	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TGFB1—ocular cancer	0.000104	0.000328	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MDM2—ocular cancer	0.000103	0.000327	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—HRAS—ocular cancer	0.000102	0.000322	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GNA11—ocular cancer	0.000101	0.00032	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CDKN1B—ocular cancer	0.0001	0.000317	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MDM2—ocular cancer	9.91e-05	0.000314	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—AKT1—ocular cancer	9.91e-05	0.000314	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.73e-05	0.000308	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HRAS—ocular cancer	9.61e-05	0.000304	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCND1—ocular cancer	9.55e-05	0.000302	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CDKN1B—ocular cancer	9.45e-05	0.000299	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GNAQ—ocular cancer	9.4e-05	0.000297	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—AKT1—ocular cancer	9.34e-05	0.000296	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MDM2—ocular cancer	9.32e-05	0.000295	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CDKN1A—ocular cancer	9.24e-05	0.000292	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HRAS—ocular cancer	9.2e-05	0.000291	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CDKN1B—ocular cancer	9.05e-05	0.000286	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCND1—ocular cancer	9.01e-05	0.000285	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—AKT1—ocular cancer	9e-05	0.000285	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—AKT1—ocular cancer	8.95e-05	0.000283	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.88e-05	0.000281	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EP300—ocular cancer	8.79e-05	0.000278	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CDKN1A—ocular cancer	8.72e-05	0.000276	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	8.65e-05	0.000274	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCND1—ocular cancer	8.63e-05	0.000273	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—ocular cancer	8.52e-05	0.00027	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	8.51e-05	0.000269	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—AKT1—ocular cancer	8.49e-05	0.000269	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	8.41e-05	0.000266	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	8.35e-05	0.000264	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EP300—ocular cancer	8.3e-05	0.000263	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—HRAS—ocular cancer	8.15e-05	0.000258	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—AKT1—ocular cancer	8.13e-05	0.000257	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MDM2—ocular cancer	8.12e-05	0.000257	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCND1—ocular cancer	8.11e-05	0.000257	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MDM2—ocular cancer	8.08e-05	0.000256	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EP300—ocular cancer	7.94e-05	0.000251	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	7.85e-05	0.000248	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNA11—ocular cancer	7.8e-05	0.000247	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MDM2—ocular cancer	7.73e-05	0.000245	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MYC—ocular cancer	7.66e-05	0.000243	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—ocular cancer	7.64e-05	0.000242	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	7.64e-05	0.000242	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.58e-05	0.00024	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HRAS—ocular cancer	7.54e-05	0.000239	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—EP300—ocular cancer	7.52e-05	0.000238	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HRAS—ocular cancer	7.5e-05	0.000237	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EP300—ocular cancer	7.47e-05	0.000236	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	7.41e-05	0.000235	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	7.37e-05	0.000233	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	7.33e-05	0.000232	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	7.3e-05	0.000231	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNAQ—ocular cancer	7.25e-05	0.00023	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MYC—ocular cancer	7.23e-05	0.000229	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—ocular cancer	7.21e-05	0.000228	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—ocular cancer	7.2e-05	0.000228	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	7.18e-05	0.000227	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MDM2—ocular cancer	7.13e-05	0.000226	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCND1—ocular cancer	7.07e-05	0.000224	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	7.06e-05	0.000223	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCND1—ocular cancer	7.04e-05	0.000223	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MDM2—ocular cancer	7.01e-05	0.000222	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MDM2—ocular cancer	7e-05	0.000221	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	6.98e-05	0.000221	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MDM2—ocular cancer	6.98e-05	0.000221	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MDM2—ocular cancer	6.95e-05	0.00022	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MYC—ocular cancer	6.92e-05	0.000219	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—ocular cancer	6.91e-05	0.000219	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MDM2—ocular cancer	6.89e-05	0.000218	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MDM2—ocular cancer	6.87e-05	0.000217	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	6.84e-05	0.000217	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	6.81e-05	0.000215	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCND1—ocular cancer	6.73e-05	0.000213	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—EP300—ocular cancer	6.67e-05	0.000211	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—ocular cancer	6.66e-05	0.000211	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—ocular cancer	6.62e-05	0.00021	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HRAS—ocular cancer	6.62e-05	0.00021	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—HRAS—ocular cancer	6.52e-05	0.000206	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	6.52e-05	0.000206	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EP300—ocular cancer	6.51e-05	0.000206	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN1B—ocular cancer	6.51e-05	0.000206	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MYC—ocular cancer	6.51e-05	0.000206	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HRAS—ocular cancer	6.5e-05	0.000206	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	6.49e-05	0.000205	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HRAS—ocular cancer	6.48e-05	0.000205	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EP300—ocular cancer	6.48e-05	0.000205	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HRAS—ocular cancer	6.46e-05	0.000204	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—ocular cancer	6.44e-05	0.000204	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	6.4e-05	0.000203	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HRAS—ocular cancer	6.4e-05	0.000202	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1B—ocular cancer	6.39e-05	0.000202	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	6.38e-05	0.000202	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	6.37e-05	0.000202	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	6.35e-05	0.000201	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	6.34e-05	0.000201	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	6.33e-05	0.0002	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—ocular cancer	6.32e-05	0.0002	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	6.3e-05	0.000199	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—ocular cancer	6.29e-05	0.000199	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	6.29e-05	0.000199	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	6.28e-05	0.000199	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	6.27e-05	0.000198	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	6.22e-05	0.000197	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCND1—ocular cancer	6.21e-05	0.000196	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	6.2e-05	0.000196	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EP300—ocular cancer	6.2e-05	0.000196	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCND1—ocular cancer	6.11e-05	0.000193	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCND1—ocular cancer	6.1e-05	0.000193	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCND1—ocular cancer	6.08e-05	0.000192	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCND1—ocular cancer	6.06e-05	0.000192	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—ocular cancer	6.02e-05	0.00019	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN1A—ocular cancer	6.01e-05	0.00019	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—ocular cancer	6e-05	0.00019	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—ocular cancer	5.98e-05	0.000189	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—ocular cancer	5.94e-05	0.000188	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	5.91e-05	0.000187	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1A—ocular cancer	5.9e-05	0.000187	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	5.88e-05	0.000186	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	5.86e-05	0.000185	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—ocular cancer	5.85e-05	0.000185	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	5.8e-05	0.000184	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	5.79e-05	0.000183	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—ocular cancer	5.75e-05	0.000182	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—ocular cancer	5.74e-05	0.000182	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—ocular cancer	5.72e-05	0.000181	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EP300—ocular cancer	5.72e-05	0.000181	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—ocular cancer	5.7e-05	0.000181	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—ocular cancer	5.68e-05	0.00018	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—ocular cancer	5.68e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—ocular cancer	5.67e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—ocular cancer	5.66e-05	0.000179	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—ocular cancer	5.65e-05	0.000179	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—ocular cancer	5.64e-05	0.000179	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	5.63e-05	0.000178	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—ocular cancer	5.63e-05	0.000178	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EP300—ocular cancer	5.62e-05	0.000178	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—EP300—ocular cancer	5.62e-05	0.000178	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EP300—ocular cancer	5.61e-05	0.000178	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—EP300—ocular cancer	5.61e-05	0.000177	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EP300—ocular cancer	5.59e-05	0.000177	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EP300—ocular cancer	5.58e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EP300—ocular cancer	5.52e-05	0.000175	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EP300—ocular cancer	5.51e-05	0.000174	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—ocular cancer	5.44e-05	0.000172	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—ocular cancer	5.4e-05	0.000171	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	5.39e-05	0.000171	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—ocular cancer	5.35e-05	0.000169	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—ocular cancer	5.31e-05	0.000168	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—ocular cancer	5.11e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—ocular cancer	5.01e-05	0.000159	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—ocular cancer	4.98e-05	0.000158	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—ocular cancer	4.97e-05	0.000157	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—ocular cancer	4.9e-05	0.000155	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—ocular cancer	4.89e-05	0.000155	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—ocular cancer	4.89e-05	0.000155	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—ocular cancer	4.88e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—ocular cancer	4.87e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—ocular cancer	4.86e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—ocular cancer	4.86e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—ocular cancer	4.85e-05	0.000153	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—EP300—ocular cancer	4.83e-05	0.000153	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—ocular cancer	4.81e-05	0.000152	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—ocular cancer	4.8e-05	0.000152	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—ocular cancer	4.8e-05	0.000152	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—ocular cancer	4.8e-05	0.000152	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	4.79e-05	0.000151	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—ocular cancer	4.66e-05	0.000147	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—ocular cancer	4.63e-05	0.000147	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—ocular cancer	4.54e-05	0.000144	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—ocular cancer	4.51e-05	0.000143	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—ocular cancer	4.46e-05	0.000141	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—ocular cancer	4.44e-05	0.00014	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—ocular cancer	4.43e-05	0.00014	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—EP300—ocular cancer	4.33e-05	0.000137	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—ocular cancer	4.24e-05	0.000134	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—ocular cancer	4.09e-05	0.000129	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—ocular cancer	4.03e-05	0.000128	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—ocular cancer	4.02e-05	0.000127	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—ocular cancer	4.02e-05	0.000127	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—ocular cancer	4e-05	0.000127	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—ocular cancer	3.99e-05	0.000126	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—EP300—ocular cancer	3.99e-05	0.000126	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—EP300—ocular cancer	3.95e-05	0.000125	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—ocular cancer	3.95e-05	0.000125	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—ocular cancer	3.94e-05	0.000125	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—ocular cancer	3.93e-05	0.000124	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—ocular cancer	3.91e-05	0.000124	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—ocular cancer	3.91e-05	0.000124	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—ocular cancer	3.85e-05	0.000122	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—ocular cancer	3.84e-05	0.000122	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—ocular cancer	3.83e-05	0.000121	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—ocular cancer	3.82e-05	0.000121	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—ocular cancer	3.78e-05	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—ocular cancer	3.77e-05	0.000119	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—ocular cancer	3.75e-05	0.000119	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—ocular cancer	3.45e-05	0.000109	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—ocular cancer	3.4e-05	0.000108	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—ocular cancer	3.4e-05	0.000107	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—ocular cancer	3.39e-05	0.000107	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—ocular cancer	3.39e-05	0.000107	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—ocular cancer	3.38e-05	0.000107	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—EP300—ocular cancer	3.38e-05	0.000107	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—ocular cancer	3.37e-05	0.000107	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—ocular cancer	3.34e-05	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—ocular cancer	3.33e-05	0.000105	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—ocular cancer	2.92e-05	9.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—ocular cancer	2.62e-05	8.29e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—EP300—ocular cancer	2.61e-05	8.25e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—ocular cancer	2.41e-05	7.62e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—ocular cancer	2.39e-05	7.56e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—ocular cancer	2.04e-05	6.46e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—ocular cancer	1.58e-05	4.99e-05	CbGpPWpGaD
